Area of research
Physiology · Surgery
Research interest
Research interests include Diet and metabolism studies, Bariatric Surgery and Outcomes, Obesity and Health Practices, and Metabolism, Diabetes, and Cancer.
Development of the European Association for the Study of Obesity (EASO) Grade-Based Framework on the Pharmacological Treatment of Obesity: Design and Methodological Aspects.
CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1.
MASLD in Adults With Type 1 Diabetes and Type 2 Diabetes Undergoing Vibration-Controlled Transient Elastography.
Abdominal Obesity, Hepatic Steatosis, Oxidative Stress and Diastolic Dysfunction in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.
Gut Microbiota in Lipodystrophies and Obesity: A Common Signature?
From Recognition to Action: Bridging Science and Policy through the Italian Obesity Law – A Model for Europe
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults
Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO)
CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1
European Association for the Study of Obesity Position Statement on the Diagnosis and Management of Obesity in Older Adults
Sex Differences in MASLD After Age 50: Presentation, Diagnosis, and Clinical Implications.
European Association for the Study of Obesity Position Statement on the Diagnosis and Management of Obesity in Older Adults.
Oral Viral DNA Profiling in Obesity, Adenomatous Polyposis, and Colorectal Cancer Identifies Human β-Papillomavirus Types as Potentially Sex-Related and Modifiable Cancer Risk Indicators.
A new framework for the diagnosis, staging and management of obesity in adults
Obesity phenotyping at the “heart” of risk stratification
Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications
Obesity is a chronic progressive relapsing disease of particular interest for internal medicine.
Metabolically healthy obesity: does it exist?
Correction: Advice of General Practitioner, of Surgeon, of Endocrinologist, and Self-Determination: the Italian Road to Bariatric Surgery
Patient motivation to lose weight: Importance of healthcare professional support, goals and self-efficacy
Patient motivation to lose weight: Importance of healthcare professional support, goals and self-efficacy.
Obesity management: at the forefront against disease stigma and therapeutic inertia
Is type 2 diabetes an adiposity-based metabolic disease? From the origin of insulin resistance to the concept of dysfunctional adipose tissue.
Spot-light on microbiota in obesity and cancer
Misperceptions and barriers to obesity management: Italian data from the ACTION-IO study.
Misperceptions and barriers to obesity management: Italian data from the ACTION-IO study
Tyrosol May Prevent Obesity by Inhibiting Adipogenesis in 3T3-L1 Preadipocytes
Tyrosol May Prevent Obesity by Inhibiting Adipogenesis in 3T3-L1 Preadipocytes.
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Physiology · Surgery →